PET/CT is now an important cancer imaging tool, both for diagnosis and staging, as well as offering prognostic information based on response. This study attempts to review the value of PET/CT in the staging of lung cancer, illustrate the potential effect on patient's management and give a short overview of newer applications. Specifically, PET/CT can improve initial staging, guide surgical and radiotherapy planning, predict tumor response and can detect early tumor recurrence